Literature DB >> 17193340

Utility of the Algase Wandering Scale in an outpatient Alzheimer's disease sample.

Jacqueline F Marcus1, Janet S Cellar, Farzaneh Pour Ansari, Donald L Bliwise.   

Abstract

BACKGROUND: Wandering represents a major problem in the management of patients with Alzheimer's disease (AD). In this study we examined the utility of the Algase Wandering Scale (AWS), a newly developed psychometric instrument that asks caregivers to assess the likelihood of wandering behavior.
METHODS: The AWS was administered to the caregivers of 40 AD patients and total and subscale scores were examined in relation to measures of mental and functional status, depressive symptoms and medication usage.
RESULTS: AWS scores were comparable, though slightly lower, than those normative values previously published. Higher scores were associated with more severe dementia. The Negative Outcome subscale showed a significant increase in reported falls or injuries in association with anti-depressant use.
CONCLUSIONS: These data provide some construct validation for the AWS as a potentially useful scale to assess wandering behaviors in AD.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17193340     DOI: 10.1002/gps.1745

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  2 in total

Review 1.  Non-pharmacological interventions for wandering of people with dementia in the domestic setting.

Authors:  D G Hermans; U Hla Htay; R McShane
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

2.  Detection of Wandering Behaviors Using a Body-Worn Inertial Sensor in Patients With Cognitive Impairment: A Feasibility Study.

Authors:  Rebecca J Kamil; Dara Bakar; Matthew Ehrenburg; Eric X Wei; Alexandra Pletnikova; Grace Xiao; Esther S Oh; Martina Mancini; Yuri Agrawal
Journal:  Front Neurol       Date:  2021-03-11       Impact factor: 4.003

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.